113 related articles for article (PubMed ID: 22207328)
1. Cystatin C as risk factor for cardiovascular events and all-cause mortality in the general population. The Tromsø Study.
Toft I; Solbu M; Kronborg J; Mathisen UD; Eriksen BO; Storhaug H; Melsom T; Løchen ML; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J
Nephrol Dial Transplant; 2012 Jul; 27(7):2780-7. PubMed ID: 22207328
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C and the risk of death and cardiovascular events among elderly persons.
Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
Meisinger C; Döring A; Löwel H;
Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
[TBL] [Abstract][Full Text] [Related]
4. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O
J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study.
Keller T; Messow CM; Lubos E; Nicaud V; Wild PS; Rupprecht HJ; Bickel C; Tzikas S; Peetz D; Lackner KJ; Tiret L; Münzel TF; Blankenberg S; Schnabel RB
Eur Heart J; 2009 Feb; 30(3):314-20. PubMed ID: 19153178
[TBL] [Abstract][Full Text] [Related]
7. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.
Nerpin E; Ingelsson E; Risérus U; Sundström J; Larsson A; Jobs E; Jobs M; Hallan S; Zethelius B; Berglund L; Basu S; Arnlöv J
Nephrol Dial Transplant; 2011 Sep; 26(9):2820-7. PubMed ID: 21335440
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment.
Lind M; Jansson JH; Nilsson TK; Järvholm LS; Johansson L
Thromb Res; 2013 Aug; 132(2):e77-82. PubMed ID: 23834818
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function.
Meng L; Yang Y; Qi LT; Wang XJ; Xu GB; Zhang BW
J Nephrol; 2012; 25(3):426-30. PubMed ID: 21928225
[TBL] [Abstract][Full Text] [Related]
10. Kidney function as a predictor of noncardiovascular mortality.
Fried LF; Katz R; Sarnak MJ; Shlipak MG; Chaves PH; Jenny NS; Stehman-Breen C; Gillen D; Bleyer AJ; Hirsch C; Siscovick D; Newman AB
J Am Soc Nephrol; 2005 Dec; 16(12):3728-35. PubMed ID: 16251239
[TBL] [Abstract][Full Text] [Related]
11. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis.
Lee M; Saver JL; Huang WH; Chow J; Chang KH; Ovbiagele B
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):675-83. PubMed ID: 20923994
[TBL] [Abstract][Full Text] [Related]
12. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.
Ix JH; Shlipak MG; Chertow GM; Whooley MA
Circulation; 2007 Jan; 115(2):173-9. PubMed ID: 17190862
[TBL] [Abstract][Full Text] [Related]
13. Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study.
Vikan T; Schirmer H; Njølstad I; Svartberg J
Eur J Endocrinol; 2009 Sep; 161(3):435-42. PubMed ID: 19542243
[TBL] [Abstract][Full Text] [Related]
14. Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population.
Oh SW; Baek SH; Kim YC; Goo HS; Heo NJ; Na KY; Chae DW; Kim S; Chin HJ
Nephrol Dial Transplant; 2012 Jun; 27(6):2284-90. PubMed ID: 22140122
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.
Margolis KL; Manson JE; Greenland P; Rodabough RJ; Bray PF; Safford M; Grimm RH; Howard BV; Assaf AR; Prentice R;
Arch Intern Med; 2005 Mar; 165(5):500-8. PubMed ID: 15767524
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C in acute heart failure without advanced renal impairment.
Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome.
Ristiniemi N; Lund J; Tertti R; Christensson A; Ilva T; Porela P; Pulkki K; Pettersson K
Clin Biochem; 2012 May; 45(7-8):535-40. PubMed ID: 22394460
[TBL] [Abstract][Full Text] [Related]
19. [Cystatin C as a mortality predictor in a hypertensive population in Extremadura, Spain].
Garcia Gallego F; Robles NR; Matias Orozco N; Mena C; Cidoncha A
Med Clin (Barc); 2015 Sep; 145(5):198-200. PubMed ID: 26051437
[TBL] [Abstract][Full Text] [Related]
20. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality.
Tsagalis G; Akrivos T; Alevizaki M; Manios E; Stamatellopoulos K; Laggouranis A; Vemmos KN
Nephrol Dial Transplant; 2009 Jan; 24(1):194-200. PubMed ID: 18728156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
